期刊文献+

肝癌合并门静脉高压症的诊治现状 被引量:6

Diagnosis and treatment of hepatocellular carcinoma with portal hypertension
下载PDF
导出
摘要 原发性肝癌(hepatocellular carcinoma,HCC)是我国常见的恶性肿瘤,HCC合并门静脉高压症在临床实践中是经常遇到的难题.HCC合并门静脉高压症患者主要死亡原因之一是食管胃底静脉曲张破裂出血.如何同时处理HCC及门静脉高压依然是肝脏外科医师关注的焦点之一.本文就HCC合并门静脉高压症的诊治概况进行简要述评. Hepatocellular carcinoma (HCC) is a common malignant tumor in China. HCC complicated with portal hypertension is a common problem in clinical practice. Bleeding from esophagogastric varices is a major cause of death in patients with HCC complicated with portal hypertension. How to treat HCC and portal hypertension simultaneously remains one of the challenges for liver surgeons. This article briefly reviews the current status of treatment of HCC with portal hypertension.
作者 王卫东 Wei-Dong Wang(Department of Hepatobiliary Surgery,Shunde Hospital,Southern Medical University(Shunde First People's Hospital of Foshan),Foshan 528300,Guangdong Province.China)
出处 《世界华人消化杂志》 CAS 2018年第24期1429-1433,共5页 World Chinese Journal of Digestology
关键词 原发性肝癌 门静脉高压症 治疗进展 Hepatocellular carcinoma Portal hypertension Treatment progression
  • 相关文献

同被引文献40

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部